Compare SRFM & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRFM | ECOR |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.5M | 100.3M |
| IPO Year | 2023 | 2018 |
| Metric | SRFM | ECOR |
|---|---|---|
| Price | $0.80 | $7.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $4.93 | ★ $19.17 |
| AVG Volume (30 Days) | ★ 5.0M | 74.6K |
| Earning Date | 11-11-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.69 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $106,557,000.00 | $32,032,000.00 |
| Revenue This Year | $21.73 | $30.85 |
| Revenue Next Year | $26.16 | $29.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $0.46 | $4.41 |
| 52 Week High | $4.50 | $12.70 |
| Indicator | SRFM | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 44.62 | 24.07 |
| Support Level | $0.66 | $5.59 |
| Resistance Level | $0.90 | $7.24 |
| Average True Range (ATR) | 0.09 | 0.67 |
| MACD | -0.03 | -0.28 |
| Stochastic Oscillator | 11.39 | 3.16 |
Surf Air Mobility Inc is a regional air mobility platform operating commuter airlines in the United States and expanding an on-demand charter marketplace for passengers in the U.S. and globally. It is also focused on developing a proprietary aviation software, aircraft electrification powertrain technology and services to enable electrification across the regional air mobility sector. The company operates in a single reportable segment, Air Mobility. The Air Mobility segment derives revenue from operating scheduled commercial air service flights, which are sold to the public mainly on a per-seat basis; through subsidized EAS revenue awards from the Department of Transportation; and by operating on-demand flights for customers on an ad-hoc, by request basis.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.